[
  {
    "ts": null,
    "headline": "Revvity: Not A Healthy Diagnosis For This Life Science Business",
    "summary": "Revvity continues to struggle post-pandemic, with poor capital allocation and stagnant business performance leading to several lost years. See why RVTY stock is a Hold.",
    "url": "https://finnhub.io/api/news?id=c61dbb5722bbd25ab11cd4fc700b6cb5b61f9e8fc0c9bf1ab8d86c9621d72d0b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753773195,
      "headline": "Revvity: Not A Healthy Diagnosis For This Life Science Business",
      "id": 136116554,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2184958576/image_2184958576.jpg?io=getty-c-w1536",
      "related": "RVTY",
      "source": "SeekingAlpha",
      "summary": "Revvity continues to struggle post-pandemic, with poor capital allocation and stagnant business performance leading to several lost years. See why RVTY stock is a Hold.",
      "url": "https://finnhub.io/api/news?id=c61dbb5722bbd25ab11cd4fc700b6cb5b61f9e8fc0c9bf1ab8d86c9621d72d0b"
    }
  },
  {
    "ts": null,
    "headline": "Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ...",
    "summary": "Revvity Inc (RVTY) surpasses EPS expectations with robust software performance, while navigating challenges in the Diagnostics segment and adjusting growth outlook.",
    "url": "https://finnhub.io/api/news?id=8059456c2aa9ba3da1d357e66db57fa7c295060653dff22e3274836f0abf04a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753772561,
      "headline": "Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ...",
      "id": 136117399,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RVTY",
      "source": "Yahoo",
      "summary": "Revvity Inc (RVTY) surpasses EPS expectations with robust software performance, while navigating challenges in the Diagnostics segment and adjusting growth outlook.",
      "url": "https://finnhub.io/api/news?id=8059456c2aa9ba3da1d357e66db57fa7c295060653dff22e3274836f0abf04a7"
    }
  }
]